On this page
At a glance
- TIF creates a partial valve using fasteners placed through an endoscope — no skin incisions.
- Guidelines consider it for selected patients without severe esophagitis and with no hiatal hernia or one of 2 cm or less.
- cTIF adds laparoscopic repair of a larger hiatal hernia in the same session, extending TIF to more patients; its evidence base is smaller.
- Radiofrequency treatment (Stretta) is a different endoscopic therapy that the ACG does not recommend.
How TIF works
Under general anesthesia, a device is passed through the mouth into the stomach alongside a flexible endoscope. The device folds tissue at the top of the stomach up against the lower esophagus and secures it with a series of fasteners, creating a partial valve a few centimeters long. The most widely studied version is called TIF 2.0, performed with the EsophyX device.
Because there are no skin incisions, recovery is usually quicker than after surgery. Temporary sore throat, chest or upper-abdominal discomfort, and a period of dietary caution are common.
Who may be a candidate
The ACG guideline suggests TIF may be considered for people with troublesome heartburn or regurgitation who prefer not to have surgery and who do not have severe esophagitis (Los Angeles grade C or D) or a hiatal hernia larger than 2 cm. The AGA describes TIF as effective in carefully selected patients. As with any anti-reflux procedure, reflux must first be confirmed by testing, and manometry should show adequate esophageal function.
TIF is generally less suitable for people with large hiatal hernias (unless combined with repair — see cTIF), severe esophagitis, long-segment Barrett’s esophagus, or significant obesity.
What the evidence shows
In the TEMPO randomized trial, all 63 participants ultimately received TIF 2.0, and 44 were evaluated at five years. Among them, troublesome regurgitation had been eliminated in 86%, and 34% were taking daily PPIs, compared with all participants before treatment. There were no serious adverse events, and three participants had later operations. Like many long-term studies, it lost some participants to follow-up, which limits certainty.
In general, TIF produces a looser valve than a laparoscopic fundoplication. Many people experience meaningful improvement, but some continue to need medication.
cTIF — hernia repair combined with TIF
Because TIF alone doesn’t address hiatal hernias larger than 2 cm, surgeons developed a combined approach, often called cTIF or HH + TIF: the hiatal hernia is repaired laparoscopically, and TIF is then performed during the same anesthetic. In one prospective study of 99 patients with hernias of 2 to 5 cm, 74% had stopped PPIs at 12 months. The evidence for cTIF is younger and smaller than for fundoplication, and long-term comparative data remain limited.
Other endoscopic options
- Stretta applies radiofrequency energy to the lower esophageal muscle. The ACG guideline recommends against it, based on the available evidence.
- Anti-reflux mucosal procedures (sometimes called ARMS or ARMA) reshape the valve by removing or scarring a small area of lining. These are newer, and evidence is still emerging.
Choosing among incisionless and surgical options
Incisionless approaches are appealing, but the right procedure depends on hernia size, test results, esophageal function, and how much reflux control you need. The treatment comparison summarizes how the options differ, and a consultation is the place to discuss which ones fit your situation.
Common questions
What is TIF, and who may be a candidate?
TIF rebuilds a partial reflux valve from inside the stomach through the mouth; it may suit people with confirmed GERD who don’t have severe esophagitis and have no hiatal hernia or one of 2 cm or less.
TIF is sometimes a good fit for people who want an alternative to long-term medication but prefer to avoid surgery, and whose anatomy fits the criteria above. Like all anti-reflux procedures, it requires reflux to be confirmed by testing and esophageal function to be checked with manometry.
Compared with surgical fundoplication, TIF typically creates a less robust valve. Many people improve substantially, but some continue to need medication. For people with larger hernias, the combined approach described below may be discussed.
What is cTIF?
cTIF is laparoscopic repair of a hiatal hernia followed by TIF in the same session, used to extend incisionless valve reconstruction to people whose hernia is too large for TIF alone.
The hiatal hernia is repaired through small abdominal incisions — returning the stomach below the diaphragm and tightening the opening — and TIF is then performed through the mouth to create the valve. Early studies in patients with hernias of roughly 2 to 5 cm have reported encouraging results, including many patients stopping daily PPIs at one year. Long-term and comparative evidence is still limited, so cTIF is one option among several to weigh with your surgeon.
Sources
- Katz PO, et al. ACG Clinical Guideline for the Diagnosis and Management of GERD. Am J Gastroenterol. 2022;117(1):27–56.
- Yadlapati R, et al. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD. Clin Gastroenterol Hepatol. 2022;20(5):984–994.
- Trad KS, et al. The TEMPO trial at 5 years — transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25(2):149–157.
- Janu P, et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF) — efficacy and safety in two community hospitals. Surg Innov. 2019;26(6):675–686.
This page is general education. It can’t account for your history, test results, or other conditions, so please discuss your situation with your own clinician.